使用活病毒疫苗进行脊髓灰质炎免疫的现状。 - Suppr

Suppr

超能文献

Present position of immunization against poliomyelitis with live virus vaccines.

作者信息

SABIN A B

出版信息

Br Med J. 1959 Mar 14;1(5123):663-80. doi: 10.1136/bmj.1.5123.663.

DOI:10.1136/bmj.1.5123.663

PMID:13629086

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1993129/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab76/1993129/213866b645b5/brmedj02962-0017-a.jpg

相似文献

Present position of immunization against poliomyelitis with live virus vaccines.使用活病毒疫苗进行脊髓灰质炎免疫的现状。

Br Med J. 1959 Mar 14;1(5123):663-80. doi: 10.1136/bmj.1.5123.663.

Vaccination against poliomyelitis with live virus vaccines. 4. A review of the present position.使用活病毒疫苗预防脊髓灰质炎。4. 当前状况综述。

Br Med J. 1958 Nov 15;2(5106):1184-6. doi: 10.1136/bmj.2.5106.1184.

Vaccination against poliomyelitis with live virus vaccines. III. The evaluation to TN and SM virus vaccines.使用活病毒疫苗预防脊髓灰质炎。III. 对TN和SM病毒疫苗的评估。

Br Med J. 1957 Jan 12;1(5010):70-4.

Vaccination against poliomyelitis with live virus vaccines. II. A trial of SM type I attenuated poliomyelitis virus vaccine.使用活病毒疫苗预防脊髓灰质炎。II. I型SM株减毒脊髓灰质炎病毒疫苗的试验。

Br Med J. 1957 Jan 12;1(5010):65-70.

Vaccination against poliomyelitis with live virus vaccines. I. A trial of TN type II vaccine.使用活病毒疫苗进行脊髓灰质炎疫苗接种。I. TN II型疫苗的试验。

Br Med J. 1957 Jan 12;1(5010):59-65.

Vaccination against poliomyelitis with live virus vaccines. 7. Effect of previous Salk vaccination on virus excretion.使用活病毒疫苗进行脊髓灰质炎疫苗接种。7. 先前接种索尔克疫苗对病毒排泄的影响。

Br Med J. 1961 Jul 29;2(5247):266-9. doi: 10.1136/bmj.2.5247.266.

[Vaccination in Poland with a live attenuated vaccine against poliomyelitis].[在波兰接种减毒活脊髓灰质炎疫苗]

Med Dosw Mikrobiol. 1960;12:1-14.

Vaccination against poliomyelitis with live virus vaccines. 5. Neutralizing antibody levels one year after vaccination.使用活病毒疫苗进行脊髓灰质炎疫苗接种。5. 接种疫苗一年后的中和抗体水平。

Br Med J. 1958 Nov 15;2(5106):1187-8. doi: 10.1136/bmj.2.5106.1187.

Vaccination against poliomyelitis; the current status of inactivated and attenuated virus vaccines.脊髓灰质炎疫苗接种；灭活疫苗和减毒活疫苗的现状

Pediatrics. 1956 Feb;17(2):287-96.

Immunization of man against poliomyelitis with attenuated preparations of living virus.

Ann N Y Acad Sci. 1955 Sep 27;61(4):1039-49. doi: 10.1111/j.1749-6632.1955.tb42564.x.

引用本文的文献

Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity.严重急性呼吸综合征冠状病毒2减毒活疫苗的间接传播及其对群体免疫的贡献。

Vaccines (Basel). 2023 Mar 14;11(3):655. doi: 10.3390/vaccines11030655.

In-vitro and in-vivo study of the interference between Rift Valley fever virus (clone 13) and Sheeppox/Limpy Skin disease viruses.裂谷热病毒（克隆 13）与绵羊痘/传染性脓疱皮炎病毒的体外与体内干扰研究。

Sci Rep. 2021 Jun 11;11(1):12395. doi: 10.1038/s41598-021-91926-5.

A Narrative Review of Pediatric Nontraumatic Spinal Cord Dysfunction.小儿非创伤性脊髓功能障碍的叙述性综述

Top Spinal Cord Inj Rehabil. 2019 Spring;25(2):112-120. doi: 10.1310/sci2502-112.

International Contributions toward the Conquest of Polio.对征服小儿麻痹症的国际贡献。

Ulster Med J. 2019 Jan;88(1):47-54. Epub 2019 Jan 22.

Poliomyelitis era in Trinidad from 1940 to 1972 and beyond: Implications for effective global health governance for its eradication.1940年至1972年及之后特立尼达的脊髓灰质炎时代：对其根除的有效全球卫生治理的启示

J Family Med Prim Care. 2018 Jul-Aug;7(4):664-670. doi: 10.4103/jfmpc.jfmpc_319_17.

Virological and Immunological Outcomes of Coinfections.病毒学和免疫学的合并感染结果。

Clin Microbiol Rev. 2018 Jul 5;31(4). doi: 10.1128/CMR.00111-17. Print 2018 Oct.

Review of the History of Non-traumatic Spinal Cord Dysfunction.非创伤性脊髓功能障碍病史回顾

Top Spinal Cord Inj Rehabil. 2017 Fall;23(4):285-298. doi: 10.1310/sci2304-285.

Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.应对脊髓灰质炎消灭阶段的挑战与机遇：未来的经验教训

J Infect Dis. 2017 Jul 1;216(suppl_1):S1-S8. doi: 10.1093/infdis/jix117.

Putting together the pieces of polio: how Dorothy Horstmann helped solve the puzzle.将小儿麻痹症的各个部分放在一起：多萝西·霍斯特曼如何帮助解决难题。

Yale J Biol Med. 2011 Jun;84(2):83-9.

I. Foreword-With a Review of the Past Experiences of the Yale Poliomyelitis Study Unit with Oral Poliovirus Vaccines.一、前言——回顾耶鲁大学脊髓灰质炎研究单位使用口服脊髓灰质炎病毒疫苗的过往经历。

Yale J Biol Med. 1962 Apr;34(5):439-46.

本文引用的文献

Virus and host factors influencing the titer of Lansing poliomyelitis virus in monkeys, cotton rats and mice.影响兰辛脊髓灰质炎病毒在猴、棉鼠和小鼠体内滴度的病毒及宿主因素。

Am J Hyg. 1950 Jan;51(1):126-33, illust. doi: 10.1093/oxfordjournals.aje.a119373.

In vitro differentiation of virulent and attenuated polioviruses by their growth characteristics on MS cells.通过强毒株和减毒脊髓灰质炎病毒在猴肾细胞（MS细胞）上的生长特性进行体外分化。

J Exp Med. 1959 Jan 1;109(1):9-24. doi: 10.1084/jem.109.1.9.

A small-scale trial of type III attenuated living poliovirus vaccine.III型脊髓灰质炎减毒活疫苗小规模试验。

Br Med J. 1958 Nov 15;2(5106):1188-93. doi: 10.1136/bmj.2.5106.1188.

Br Med J. 1958 Nov 15;2(5106):1187-8. doi: 10.1136/bmj.2.5106.1187.

[Active immunization against poliomyelitis with an attenuated virus vaccine. II. First report on the use of the Sabin vaccine in the Netherlands].

Ned Tijdschr Geneeskd. 1958 Jun 14;102(24):1144-9.

Preliminary report on mass vaccination of man with live attenuated poliomyelitis virus in the Belgian Congo and Ruanda-Urundi.关于在比属刚果和卢旺达-乌隆迪对人群接种减毒活脊髓灰质炎病毒的初步报告。

Br Med J. 1958 Jul 26;2(5090):187-90. doi: 10.1136/bmj.2.5090.187.

The degree and duration of poliomyelitis virus excretion among vaccinated household contacts of clinical cases of poliomyelitis.脊髓灰质炎临床病例的接种疫苗家庭接触者中脊髓灰质炎病毒排泄的程度和持续时间。

Pediatrics. 1958 Jul;22(1, Part 1):33-40.

Effect of sodium bicarbonate concentration on plaque formation of virulent and attenuated polioviruses.碳酸氢钠浓度对强毒株和减毒脊髓灰质炎病毒斑块形成的影响。

J Immunol. 1958 Apr;80(4):282-93.

Poliomyelitis: comparison of responses of vaccinated and naturally immune humans to ingestion of attenuated poliovirus.脊髓灰质炎：接种疫苗的人和自然免疫的人摄入减毒脊髓灰质炎病毒后的反应比较

Trans Assoc Am Physicians. 1957;70:91-101.

On the rise and decline of poliovirus antibodies in different human populations.不同人群中脊髓灰质炎病毒抗体的消长情况

Am J Hyg. 1957 Nov;66(3):342-62. doi: 10.1093/oxfordjournals.aje.a119907.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验